Article
Are TP53 mutations all alike?
Hematology. American Society of Hematology. Education Program - 6 Dec 2024
Wong Terrence N, Link Daniel C
Abstract excerpt
TP53 is mutated in 10 to 15% of cases of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and is associated with a previous exposure to cytotoxic therapy, complex cytogenetic abnormalities, and a poor prognosis. Recent data have established the importance of TP53-mutant allele status, the determination of which requires specific genetic testing. Compared with monoallelic disease, multihit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
